Skip to main content
Fig. 6 | European Journal of Medical Research

Fig. 6

From: CHKB-AS1 enhances proliferation and resistance to NVP-BEZ235 of renal cancer cells via regulating the phosphorylation of MAP4 and PI3K/AKT/mTOR signaling

Fig. 6

CHKB-AS1 affected drug sensitivity through PI3k/Akt/mTOR signaling in a MAP4-dependent manner. A Western blot showed that CHKB-AS1 and MAP4 expression significantly regulated the phosphorylated activation of PI3k/Akt/mTOR signaling. B, C MAP4 can enhance the proliferation and NVP-BEZ235 resistance through colony formation assay

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us